A NOTE FROM BOB
Coronavirus testing? There's an ETF for that. Well, not just for coronavirus, but for testing in general. The ETFMG Treatments, Testing and Advancements ETF (GERM) debuted last week. The 56 companies included are all engaged in research and development, testing and development of therapeutics and vaccines.
For more analysis and actionable insights, catch me live on Mondays at 1 on ETF Edge. KEY STORIES
IN CASE YOU MISSED IT
|
Jumat, 19 Juni 2020
ETF Edge Newsletter
Langganan:
Posting Komentar (Atom)
Tidak ada komentar:
Posting Komentar